These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 579493

  • 1. Treatment of anti-factor VIII antibodies.
    Blatt PM, White GC, McMillan CW, Roberts HR.
    Thromb Haemost; 1977 Aug 31; 38(2):514-23. PubMed ID: 579493
    [Abstract] [Full Text] [Related]

  • 2. Inhibitor antibodies to factor VIII and factor IX: management.
    Lusher JM.
    Semin Thromb Hemost; 2000 Aug 31; 26(2):179-88. PubMed ID: 10919411
    [Abstract] [Full Text] [Related]

  • 3. [Successful induction of immune tolerance and novel hemostatic effects in a hemophilia A with high-responder inhibitor by regular infusions of factor VIII].
    Shima M, Sawamoto Y, Kamisue M, Shibata Y, Tuzi S, Kuwabara M, Tanaka I, Tanizawa T, Tanaka A, Ueda M, Kakishita E, Yoshioka A.
    Rinsho Ketsueki; 1996 Nov 31; 37(11):1303-8. PubMed ID: 8960666
    [Abstract] [Full Text] [Related]

  • 4. A survey of the effectiveness of prothrombin complex concentrates in controlling hemorrhage in patients with hemophilia and anti-Factor VIII antibodies.
    Blatt PM, Ménaché D, Roberts HR.
    Thromb Haemost; 1980 Aug 29; 44(1):39-42. PubMed ID: 6775386
    [Abstract] [Full Text] [Related]

  • 5. Hemophilia. Strategies for the treatment of inhibitor patients.
    Ingerslev J.
    Haematologica; 2000 Oct 29; 85(10 Suppl):15-20. PubMed ID: 11187863
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experience.
    Brettler DB, Forsberg AD, Levine PH, Aledort LM, Hilgartner MW, Kasper CK, Lusher JM, McMillan C, Roberts H.
    Arch Intern Med; 1989 Jun 29; 149(6):1381-5. PubMed ID: 2499293
    [Abstract] [Full Text] [Related]

  • 8. [Hemophiliacs with inhibitor. Experience at the Center of Medical Action for Hemophilia of the S. José Hospital].
    Diniz MJ, Dias Francisco F, Tavares ML, Leal I.
    Acta Med Port; 1992 Apr 29; 5(4):178-80. PubMed ID: 1605065
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of inhibitor patients with activated prothrombin complex concentrates.
    Penner JA.
    Prog Clin Biol Res; 1984 Apr 29; 150():291-308. PubMed ID: 6431434
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Early experience with the use of anti-inhibitor coagulant complex to treat bleeding in hemophiliacs with inhibitors to factor VIII.
    Kantrowitz JL, Lee ML, McClure DA, Kingdon HS, Thomas WR.
    Clin Ther; 1987 Apr 29; 9(4):405-19. PubMed ID: 3111706
    [Abstract] [Full Text] [Related]

  • 14. Treatment of the bleeding inhibitor patient.
    Astermark J.
    Semin Thromb Hemost; 2003 Feb 29; 29(1):77-86. PubMed ID: 12640569
    [Abstract] [Full Text] [Related]

  • 15. The effect of activated prothrombin-complex concentrate (FEIBA) on joint and muscle bleeding in patients with hemophilia A and antibodies to factor VIII. A double-blind clinical trial.
    Sjamsoedin LJ, Heijnen L, Mauser-Bunschoten EP, van Geijlswijk JL, van Houwelingen H, van Asten P, Sixma JJ.
    N Engl J Med; 1981 Sep 24; 305(13):717-21. PubMed ID: 6790990
    [Abstract] [Full Text] [Related]

  • 16. Inhibitor treatment using unactivated prothrombin complex concentrates: the Pennsylvania experience--1978-1982.
    Eyster ME, Spero JA, Catalano PM, Gill FM, Lusch CJ, Kajani MK, Barron LE, DeGreen HP, Shapiro SS, Lewis JH.
    Prog Clin Biol Res; 1984 Sep 24; 150():309-22. PubMed ID: 6431435
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prevalence of the intron 22 inversion of the factor VIII gene and inhibitor development in Polish patients with severe hemophilia A.
    Sawecka J, Skulimowska J, Windyga J, Lopaciuk S, Kościelak J.
    Arch Immunol Ther Exp (Warsz); 2005 Sep 24; 53(4):352-6. PubMed ID: 16088320
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibitors in young boys with haemophilia.
    Lusher JM.
    Baillieres Best Pract Res Clin Haematol; 2000 Sep 24; 13(3):457-68. PubMed ID: 11030045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.